Journals / SDÜ Tıp Fakültesi Dergisi / 2020 / Cilt: 27 - Sayı: 4

Prognostic Evaluation of Systemic Immune Inflammation Index in Sudden Idiopathic Sensorineural Hearing Loss

Ani İdiyopatik Sensorinöral İşitme Kaybında Sistemik İmmün İnflamasyon İndeksinin Değerlendirilmesi

Pages
455–461
Publication Date
2020-12-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Studies with more participants are needed to demonstrate the predictive value of SII in SISNHL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate the prognostic value of systemic immune inflammation index (SII) in sudden idiopathic sensorineural hearing loss (SISNHL).
📊
Key Findings & Data:Results: The mean SII of the three groups significantly differed (p= 0.002).
💡
Conclusion & Impact:Studies with more participants are needed to demonstrate the predictive value of SII in SISNHL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ani İşitme Kaybı · Biyomarkerlar · Prognoz

Abstract

Objective: This study aimed to investigate the prognostic value of systemic immune inflammation index (SII) in sudden idiopathic sensorineural hearing loss (SISNHL). Methods: Eighty-nine patients diagnosed with SISNHL were included in this study. SII was calculated from the complete blood count when the patients were hospitalised. The patients were treated in accordance with our routine SISNHL protocol. Hearing recovery was evaluated in accordance with Siegel’s criteria, and two main groups were created (complete and incomplete recovery groups). The control group consisted of patients who were admitted to our clinic for hearing examination. SIIs were statistically analysed amongst these three groups (control, complete recovery and incomplete recovery groups). Results: The mean SII of the three groups significantly differed (p= 0.002). The control group significantly differed from the two other groups (complete recovery group: p= 0.023, incomplete recovery group: p= 0.048). The complete recovery group did not significantly differ from the incomplete recovery group (p= 0.950). Conclusion: SII had no prognostic value in patients diagnosed with SISNHL. However, SIIs were significantly higher in the patient groups diagnosed with SISNHL than those in the control group. This finding supports the predictive value of SII in SISNHL. Studies with more participants are needed to demonstrate the predictive value of SII in SISNHL.

Özet

Amaç: Bu çalışma, ani idiyopatik sensorinöral işitme kaybında (AİSNİK) sistemik immün inflamasyon indeksinin (SII) prognostik ve prediktif değerini araştırmayı hedeflemiştir. Gereç ve Yöntem: AİSNİK tanısı almış 86 hasta çalışmaya dahil edildi. Hastalar hastaneye yatırıldığında tam kan sayımından SII hesaplandı. Hastalar rutin AİSNİK protokolümüze göre tedavi edildi. İşitmenin iyileşmesi Siegel kriterlerine göre değerlendirildi ve iki ana grup oluşturuldu (tam ve tam olmayan iyileşme grupları). Kontrol grubu işitme muayenesi için kliniğimize başvuran hastalardan oluşmaktaydı. Üç grup arasında SII'lar istatistiksel olarak analiz edildi (kontrol, tam iyileşme ve tam olmayan iyileşme grupları). Bulgular: Üç grubun SII ortalamaları anlamlı olarak farklıydı (p = 0.002). Kontrol grubu diğer iki gruptan anlamlı olarak farklıydı (tam iyileşme grubu: p = 0.023, tam olmayan iyileşme grubu: p = 0.048). Tam iyileşme grubu ile tam olmayan iyileşme grubu arasında anlamlı fark yoktu (p = 0.950). Sonuç: AİSNİK tanısı alan hastalarda SII'ın prognostik değeri yoktu. Bununla birlikte, SII'lar AİSNİK tanısı alan hasta gruplarında kontrol grubuna göre anlamlı olarak daha yüksekti. Bu bulgu AİSNİK'de SII'ın prediktif değerini desteklemektedir. AİSNİK'de SII'ın prediktif değerini göstermek için daha fazla katılımcının olduğu çalışmalara ihtiyaç vardır.

🔖

Cite This Article

KUMBUL, Y. Ç., YASAN, H., TÜZ, M., OKUR, E., SİVRİCE, M. E., BÜYÜKÇELİK, B. (2020). Prognostic Evaluation of Systemic Immune Inflammation Index in Sudden Idiopathic Sensorineural Hearing Loss. SDÜ Tıp Fakültesi Dergisi, Cilt: 27 - Sayı: 4, 455–461. https://ajindex.com/articles/799453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensorineural hearing loss. Lancet 2010;375:1203–11. doi:10.1016/s0140-6736(09)62071-7
  2. Byl FM. Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 1984;94:647–61
  3. O’Malley MR, Haynes DS. Sudden hearing loss. Otolaryngol Clin North Am 2008;41(3):633-49. doi: 10.1016/j.otc.2008.01.009
  4. Hiramatsu M, Teranishi M, Uchida Y, Nishio N, Suzuki H, Kato K, et al. Polymorphisms in genes involved in inflammatory pathways in patients with sudden sensorineural hearing loss. J Neurogenet 2012; 26(3-4):387-96. doi: 10.3109/01677063.2011.652266
  5. M. Hoffman, A. Blum, R. Baruch, E. Kaplan, M. Benjamin. Leukocytes and coronary heart disease. Atherosclerosis 2004;172(1):1-6. doi: 10.1016/s0021-9150(03)00164-3
  6. Chen, L., Zhang, G., Zhang, Z., Wang, Y., Hu, L., Wu, J. Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Medicine 2018; 97(38):e12492. doi: 10.1097/MD.0000000000012492
  7. Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immuneinflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014; 20(23):6212-22. doi: 10.1158/1078-0432.CCR-14-0442
  8. Geng Y, Shao Y, Zhu D, Zheng X, Zhou Q, Zhou W, et al. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis. Sci Rep 2016;6:39482. doi: 10.1038/srep39482
  9. Jiang W, Chen Y, Huang J, Xi D, Chen J, Shao Y, et al. Systemic immune-inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma: a propensity score-matched analysis. Oncotarget 2017; 8(39):66075-86. doi: 10.18632/oncotarget.19796
  10. Eltohami YI, Kao HK, Lao WW, Huang Y, Abdelrahman M, Liao CT, et al. The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2018; 158(6):1042-50. doi: 10.1177/0194599817751678
  11. L. Siegel. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975; 8(2):467-73
  12. Pecorari G, Riva G, Naqe N, Bruno G, Nardo M, Albera R. Long-term Audiometric Outcomes in Unilateral Sudden Sensorineural Hearing Loss without Recurrence. J Int Adv Otol 2019; 15(1):56-61. doi: 10.5152/iao.2019.6670
  13. Huafeng Y, Hongqin W, Wenna Z, Yuan L, Peng X. Clinical c